Browsing Tag
glioblastoma
16 posts
Why Hemispherian’s FDA-cleared GLIX1 trial could be a turning point for brain cancer therapy
Hemispherian gets FDA clearance for GLIX1 Phase 1 trial in glioblastoma. Find out how this novel therapy targets DNA repair to combat deadly brain tumors.
August 5, 2025
TME Pharma expands AI-driven drug discovery with Aimed Analytics partnership
TME Pharma, a biotechnology company pioneering therapies that target the tumor microenvironment, has announced a strategic collaboration with…
January 29, 2025
Immunomic Therapeutics begins ITI-1001 Phase 1 trial in glioblastoma
Immunomic Therapeutics, Inc., a clinical-stage biotech company specializing in nucleic acid immunotherapy platforms, has dosed the first patient…
August 24, 2023
Gan & Lee gets EMA orphan drug status for GLR2007 in glioma
Gan & Lee Pharmaceuticals has been granted orphan drug designation for GLR2007 from the European Medicine Agency (EMA)…
April 6, 2021
Kazia Therapeutics gets fast track status for paxalisib in glioblastoma
Kazia Therapeutics, an Australian oncology company, has secured fast track designation (FTD) from the US Food and Drug…
August 21, 2020
Denovo Biopharma gets FDA approval to launch phase 2b GBM trial for DB102
Denovo Biopharma has secured approval from the US Food and Drug Administration (FDA) to launch its phase 2b…
October 16, 2019